Dr. Stephen Leeb's  Instablog

Three seemingly disparate news items last week strongly suggest that the investment world is bifurcating into commodity and non-commodity investments – or if you will long-term winners and long-term losers.

The end of last week brought two important announcements, both of which are relevant to our investments, though not terribly cheerful.
 

At my annual medical exam last week, my physician told me something that blew me away. Twelve months ago, when I last saw him, he advised me to take selenium supplements. Selenium is a mineral which can be harmful in large doses. In fact, too much can cause side-effects such as hair loss, lethargy, etc. However, your body does need a small amount of selenium for healthy cell functioning. More to the point, many studies in the past suggested that selenium could inhibit the growth of prostate cancer cells. Consequently, physicians across the country have been telling men my age to take a little extra selenium. I followed my doctor's advice, and have been taking selenium for the past year, in addition to some other nutrients such as Vitamin E, which he also recommended.
 

The big question remains: will we experience inflation or deflation in the months ahead? The good news for investors in gold is that it doesn't really matter. Precious metals will do well in either scenario.